ArticleCancer science2024

Outcomes in non-small cell lung cancer with uncommon epidermal growth factor receptor L858 substitutions under first-line epidermal growth factor receptor tyrosine kinase inhibitors: A large real-world cohort study.

Youyou Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.